Teva restructuring puts R&D programs on the chopping block | Fierce Biotech
TEVA brandbook | PPT
US states accuse Teva and other drugmakers of colluding to inflate prices over 1,000%
Generic-Drug Labeling Strategy Likely to Survive Teva Rehearing - Bloomberg
Drugmakers are abandoning cheap generics, and now US cancer patients can't get meds, say doctors
Teva | Partnership | Direct Relief
Hard label: GSK edict forces generics to 'reassess position' | Managing Intellectual Property
Generic Crestor Wins Approval, Dealing a Blow to AstraZeneca - The New York Times
Teva to pay $225 million fine and divest cholesterol drug to settle price-fixing charges | CNN Business
Brian Leaf - Director, AR&D - Teva Pharmaceuticals | LinkedIn
Drugmakers Are Abandoning Cheap Generics, and Now US Cancer Patients Can't Get Meds - Nashville Medical News - Healthcare News for Medical Professionals
Gilead Sciences - Wikipedia
Teva Pharmaceuticals Acquisition - PL Developments
Gilead Will Donate 200,000 Bottles of Truvada a Year to US Government
Teva Announces New Brand Positioning and Visual Identity in North America
Glaxo's Win in Case Against Teva Lifts Other Drugmakers - Bloomberg
About Teva
Teva Branded Pharmaceutical Products R&D;, . An electronic inhaler add-on module which store and transmit information related to inhaler use (eModule) PDR0000401 FCC ID 2AJVSPDR0000401
/cloudfront-us-east-2.images.arcpublishing.com/reuters/M4W63E6ZORL2PA57TA7CV7OIOA.jpg "Drugmakers agree to halve prices to get on China state insurance list | Reuters")
Drugmakers agree to halve prices to get on China state insurance list | Reuters
41 state attorneys general subpoena opioid manufacturers | CNN
Simerdeep Singh Gupta, MS, Ph.D. - Teva Pharmaceuticals | LinkedIn
The most influential people in biopharma today | Fierce Biotech
Federal Circuit Panel Rehears Skinny Label Case (GSK v. Teva) | Biosimilars Law Bulletin
Teva Canada Provides New Patient Resource to Empower Those Living with Chronic Conditions | Business Wire
Teva, Glenmark enter deferred prosecution deal DOJ over price fixing
Fed. Circuit Patent Ruling in Teva v. Galderma
Jennifer Moore, MBA - Sr. Director Commercial Training and Development - United Therapeutics | LinkedIn
